Hemostemix Stock Holdings Turnover
HEM Stock | CAD 0.07 0.01 12.50% |
Hemostemix fundamentals help investors to digest information that contributes to Hemostemix's financial success or failures. It also enables traders to predict the movement of Hemostemix Stock. The fundamental analysis module provides a way to measure Hemostemix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hemostemix stock.
Hemostemix | Holdings Turnover |
Hemostemix Company Holdings Turnover Analysis
Hemostemix's Holding Turnover is calculated by adding up all the transactions for the year, dividing it by 2 and then dividing it again by the total fund holdings. Holding Turnover is the rate at which funds or ETFs replace their investment holdings on an annual basis. In other words it measures how quickly a fund turns over its holdings during the fiscal year.
Hemostemix Holdings Turnover Driver Correlations
Understanding the fundamental principles of building solid financial models for Hemostemix is extremely important. It helps to project a fair market value of Hemostemix Stock properly, considering its historical fundamentals such as Holdings Turnover. Since Hemostemix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Hemostemix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Hemostemix's interrelated accounts and indicators.
Click cells to compare fundamentals
Investor can think of Holding Turnover as a percentage of a fund's assets that have turned over in the past year. Typically, a high annual turnover ratio implies that fund managers made a lot of buying and selling. The higher the annual turnover, the higher the expense ratio for the fund.
Competition |
Hemostemix Inventory Turnover
Inventory Turnover |
|
According to the company disclosure, Hemostemix has a Holdings Turnover of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Canada stocks average (which is currently at 0.0).
Hemostemix Holdings Turnover Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hemostemix's direct or indirect competition against its Holdings Turnover to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hemostemix could also be used in its relative valuation, which is a method of valuing Hemostemix by comparing valuation metrics of similar companies.Hemostemix is currently under evaluation in holdings turnover category among its peers.
Hemostemix Fundamentals
Return On Asset | -3.49 | ||||
Current Valuation | 15.96 M | ||||
Shares Outstanding | 140.64 M | ||||
Shares Owned By Insiders | 9.54 % | ||||
Number Of Shares Shorted | 11.93 K | ||||
Price To Earning | (1.70) X | ||||
Price To Book | 27.76 X | ||||
EBITDA | (2.16 M) | ||||
Net Income | (2.5 M) | ||||
Cash And Equivalents | 49.36 K | ||||
Total Debt | 4.32 M | ||||
Current Ratio | 0.05 X | ||||
Book Value Per Share | (0.09) X | ||||
Cash Flow From Operations | (1.5 M) | ||||
Short Ratio | 0.17 X | ||||
Earnings Per Share | (0.03) X | ||||
Target Price | 0.96 | ||||
Beta | 0.19 | ||||
Market Capitalization | 9.84 M | ||||
Total Asset | 313.76 K | ||||
Retained Earnings | (63.27 M) | ||||
Working Capital | (2.56 M) | ||||
Net Asset | 313.76 K |
About Hemostemix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hemostemix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemostemix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemostemix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hemostemix Stock Analysis
When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.